08.07.2021 23:00:00

Thermo Fisher Scientific Declares Quarterly Dividend

WALTHAM, Mass., July 8, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.26 per common share, payable on October 15, 2021, to shareholders of record as of September 15, 2021.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $30 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 80,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com

Thermo Fisher Scientific logo (PRNewsfoto/Thermo Fisher Scientific)

Media Contact Information:
Ron O'Brien
781-622-1242
ron.obrien@thermofisher.com
www.thermofisher.com

Investor Contact Information:
Rafael Tejada
781-622-1356
rafael.tejada@thermofisher.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/thermo-fisher-scientific-declares-quarterly-dividend-301328188.html

SOURCE Thermo Fisher Scientific

Analysen zu Thermo Fisher Scientific Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Thermo Fisher Scientific Inc 501,20 1,74% Thermo Fisher Scientific Inc